Two recent studies document the positive effects of gastric bypass on hyperlipidemia and blood pressure as well as glycemia for patients with mild obesity and type 2 diabetes. More »
Betatrophin, a naturally occurring hormone, may help restore beta cell mass, and so insulin production, lost through the pathologic changes of the diabetic process. More »
There is insufficient evidence to determine that hormonal contraceptives do not influence glucose and lipid metabolism in women with diabetes mellitus, concluded a systematic review conducted by the Cochrane Fertility Regulation Group. More »
The patient, an active 49-year-old man, had an HbA1c of 8.6 after diabetes was first diagnosed. It’s now 7.6 with metformin and lifestyle measures. Is the current A1c goal adequate, or should you treat more aggressively? More »
Recommendations consider the whole patient, the spectrum of risks and complications for the patient, and evidence-based approaches to treatment. More »
Linagliptin achieves significant improvements in glycemic control in a pooled analysis of clinical trials. And a separate randomized trial shows that it can spare insulin and protect kidneys in patients with type 2 diabetes and severe renal insufficiency. More »
More than 90% of patients with diabetes mellitus receive their care from primary care physicians. This compact slide show provides visual presentations of a range of DM-related problems. More »
An independent panel convened by the National Institutes of Health has concluded that there is insufficient evidence to adopt a 1-step approach to the diagnosis of gestational diabetes mellitus (GDM). More »
In patients with gestational diabetes mellitus, metformin is an effective alternative to insulin, according to the findings of a recent single-center randomized controlled study. More »
A new risk engine predicts macro- and microvascular complications of diabetes more reliably than the one from the UK Prospective Diabetes Study. More »
